World's Best Scientists 2026 revealed!
Tore Saxne

Tore Saxne

D-Index & Metrics

Medicine

D-Index
85
Citations
25120
World Ranking
14661
National Ranking
273

Overview

Tore Saxne is affiliated with Lund University in Sweden and focuses research primarily within the field of Medicine. Their work concentrates on several subfields, including Rheumatology, Epidemiology, Hematology, Pulmonary and Respiratory Medicine, and Immunology. The main topics addressed in their publications encompass Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Pneumonia and Respiratory Infections, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Immunodeficiency and Autoimmune Disorders, Tuberculosis Research and Epidemiology, and Blood Coagulation and Thrombosis Mechanisms.

Throughout their career, Saxne has contributed to various scientific journals and venues, with frequent publications including:

  • Research Square (Research Square)
  • The Journal of Immunology
  • Arthritis & Rheumatology
  • Vaccine
  • BMC Rheumatology

Recent papers by Saxne highlight studies on autoimmune and infectious disease mechanisms as well as therapeutic outcomes. Key publications include:

  • "Apolipoprotein E Triggers Complement Activation in Joint Synovial Fluid of Rheumatoid Arthritis Patients by Binding C1q", 2020, The Journal of Immunology
  • "Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy: A Swedish Nationwide Register Study", 2021, Arthritis & Rheumatology
  • "Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis", 2022, Vaccine
  • "Cardiovascular disease risk in early rheumatoid arthritis: the impact of cartilage oligomeric matrix protein (COMP) and disease activity", 2023, BMC Rheumatology
  • "Reduced Risk of Serious Pneumococcal Infection Up to 10 Years After 7-Valent Pneumococcal Conjugate Vaccine in Arthritis Patients", 2021, Research Square (Research Square)

Saxne frequently collaborates with several coauthors, including:

  • Meliha C Kapetanovic
  • Johanna Nagel
  • Chanchai Manuswin
  • Martin Englund
  • Jan-Åke Nilsson

Best Publications

  • Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum.

    Tore Saxne;Michael Palladino;Dick Heinegård;Norman Talal

  • Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis

    Lennart T H Jacobsson;Carl Turesson;Anders Gülfe;Meliha C Kapetanovic

  • Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists

    J Askling;C M Fored;Eva Baecklund;L Brandt

  • Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab.

    Klaus Bendtzen;Pierre Geborek;Morten Svenson;Lotta Larsson

  • The role of the cartilage matrix in osteoarthritis

    Dick Heinegård;Tore Saxne

  • Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden.

    Johan Askling;C. Michael Fored;Lena Brandt;Eva Baecklund

  • Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists

    J Askling;CM Fored;L Brandt;E Baecklund

  • IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.

    L.A.B. Joosten;M.M.A. Helsen;T. Saxne;F.A.J. van de Loo

  • Prognostic laboratory markers of joint damage in rheumatoid arthritis

    Elisabet Lindqvist;Kerstin Eberhardt;Klaus Bendtzen;Dick Heinegard

  • CARTILAGE OLIGOMERIC MATRIX PROTEIN: A NOVEL MARKER OF CARTILAGE TURNOVER DETECTABLE IN SYNOVIAL FLUID AND BLOOD

    Tore Saxne;Dick Heinegård

  • Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

    L. Van Bon;L. Van Bon;A. J. Affandi;A. J. Affandi;J. Broen;J. Broen;R. B. Christmann

  • Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas

    Pierre Geborek;Anna Bladström;Carl Turesson;Anders Gulfe

  • Classification of osteoarthritis biomarkers: a proposed approach

    D. C. Bauer;D. J. Hunter;S. B. Abramson;M. Attur

  • Time‐dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists

    Johan Askling;C Michael Fored;Lena Brandt;Eva Baecklund

  • Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis

    Meliha C Kapetanovic;Tore Saxne;Anders Sjöholm;Lennart Truedsson

  • Radiographic osteoarthritis of the knee classified by the Ahlbäck and Kellgren & Lawrence systems for the tibiofemoral joint in people aged 35–54 years with chronic knee pain

    Ingemar F Petersson;Torsten Boegård;Tore Saxne;Alan J Silman

  • Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register

    Johan Askling;Eva Baecklund;F. Granath;P. Geborek

  • Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden

    Pierre Geborek;Meliha Crnkic;I F Petersson;Tore Saxne

  • Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis

    Andrew Kinloch;Karin Lundberg;Robin Wait;Natalia Wegner

  • Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?

    Johan Askling;Ronald F. van Vollenhoven;Fredrik Granath;Pauline Raaschou

Frequent Co-Authors

Dick Heinegård
Dick Heinegård Lund University
Anna M. Blom
Anna M. Blom Lund University
Lars Klareskog
Lars Klareskog Karolinska Institute
Johan Askling
Johan Askling Karolinska Institute
Martin Englund
Martin Englund Lund University
Göran Jönsson
Göran Jönsson Lund University
Anthony G. Wilson
Anthony G. Wilson University College Dublin
Elisabeth Brouwer
Elisabeth Brouwer University Medical Center Groningen
René E. M. Toes
René E. M. Toes Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in medicine or healthcare, there are a variety of online degree pathways to explore. Many students pursue nursing as a flexible, in-demand starting point. For current registered nurses, there are cheap rn to bsn programs that offer a cost-effective way to advance your education and open doors to leadership roles.

For those aiming higher, many universities now feature online phd programs in nursing, allowing professionals to earn a doctorate without putting their careers on hold. If you have a non-nursing bachelor’s degree but want to pivot into advanced practice, direct entry np programs for non nurses online provide a streamlined transition.

Entry requirements vary widely, so those looking for flexible options may prefer the easiest nursing programs to get into. With so many accredited online programs and alternative routes, students can find the pathway that fits their academic background and career goals.

Best Scientists Citing Tore Saxne

Trending Scientists